Quantitative studies are the gold standard for establishing causality and drawing conclusions that can be generalized beyond the population studied. However, quantitative research methods also often lack contextual considerations and perspectives that can be further informed by qualitative approaches.
The high costs often associated with treatments for rare diseases can make it challenging for patients to gain access to these life-changing therapies. PRECISIONheor experts have led research in a number of innovative studies on rare diseases to help get these treatments into the hands of the patients that need them the most.
This month PRECISIONheor would like to highlight the work and expertise of Senior Director Ivar Jensen.
Despite 100-year since its discovery, insulin – a life-saving medicine – remains inaccessible to millions around the world, owing to limited availability and high cost. Insulin is manufactured in just 20 countries worldwide, leaving all the other countries dependent on imports to meet the needs of their patients with diabetes.
Quantification of temporal transmission potential of an infectious disease has been a challenge. Most mathematical models assume that the transmission rate of an infectious disease either does not vary over time or change in fixed pre-determined adhoc ways.
Several clinical scoring systems have gradually emerged for liver injury diagnosis, but certain serious inherent deficiencies currently limit their predictive value. Precision's Anuj Mubayi and co-author Aditi Ghosh report on their first of its kind study to use mathematical modeling to provide an accurate novel prognosis method to improve tools for diagnosis and clinical management of drug-induced acute liver injury and heart-attack-influenced ischaemic hepatitis liver injury.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
